Literature DB >> 3133168

All-trans retinoic acid with or without low dose cytosine arabinoside in acute promyelocytic leukemia. Report of 6 cases.

M E Huang, Y C Ye, S R Chen, J C Zhao, L J Gu, J R Cai, L Zhao, J X Xie, Z X Shen, Z Y Wang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3133168

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN： 0366-6999            Impact factor:   2.628


× No keyword cloud information.
  14 in total

Review 1.  p53-Independent, normal stem cell sparing epigenetic differentiation therapy for myeloid and other malignancies.

Authors:  Yogen Saunthararajah; Pierre Triozzi; Brian Rini; Arun Singh; Tomas Radivoyevitch; Mikkael Sekeres; Anjali Advani; Ramon Tiu; Frederic Reu; Matt Kalaycio; Ed Copelan; Eric Hsi; Alan Lichtin; Brian Bolwell
Journal:  Semin Oncol       Date:  2012-02       Impact factor: 4.929

Review 2.  Differentiation therapy of leukemia: 3 decades of development.

Authors:  Daniel Nowak; Daphne Stewart; H Phillip Koeffler
Journal:  Blood       Date:  2009-02-12       Impact factor: 22.113

3.  Top five medical innovations in China mainland since Xinhai revolution [1911]: results of AME survey-002.

Authors:  Yì-Xiáng J Wáng; Fan Xiao
Journal:  Quant Imaging Med Surg       Date:  2015-06

4.  A PMLRARalpha transgene initiates murine acute promyelocytic leukemia.

Authors:  D Brown; S Kogan; E Lagasse; I Weissman; M Alcalay; P G Pelicci; S Atwater; J M Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

Review 5.  What are we learning from the cancer genome?

Authors:  Eric A Collisson; Raymond J Cho; Joe W Gray
Journal:  Nat Rev Clin Oncol       Date:  2012-09-11       Impact factor: 66.675

6.  Targeting Transcription Factors in Cancer.

Authors:  Anand S Bhagwat; Christopher R Vakoc
Journal:  Trends Cancer       Date:  2015-09-01

7.  Clinical Responsiveness to All-trans Retinoic Acid Is Potentiated by LSD1 Inhibition and Associated with a Quiescent Transcriptome in Myeloid Malignancies.

Authors:  Mina M Tayari; Helena G Dos Santos; Ronan T Swords; Justin M Watts; Deukwoo Kwon; Terrence J Bradley; Amber Thomassen; Charles Chen; Yvonne Dinh; Aymee Perez; Arthur Zelent; Lluis Morey; Luisa Cimmino; Ramin Shiekhattar
Journal:  Clin Cancer Res       Date:  2021-01-25       Impact factor: 13.801

8.  Interaction of antihistaminic drugs with human translationally controlled tumor protein (TCTP) as novel approach for differentiation therapy.

Authors:  Ean-Jeong Seo; Thomas Efferth
Journal:  Oncotarget       Date:  2016-03-29

9.  c-MYC and reactive oxygen species play roles in tetrandrine-induced leukemia differentiation.

Authors:  Guixian Wu; Ting Liu; Han Li; Yafang Li; Dengju Li; Wenhua Li
Journal:  Cell Death Dis       Date:  2018-05-01       Impact factor: 8.469

10.  Differentiation therapy and the mechanisms that terminate cancer cell proliferation without harming normal cells.

Authors:  Francis O Enane; Yogen Saunthararajah; Murray Korc
Journal:  Cell Death Dis       Date:  2018-09-06       Impact factor: 8.469
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.